Gamma-Diketones Activate Wnt Pathway for Bone Regeneration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for osteoporosis, osteoarthropathy, bone defects, and neurodegenerative diseases lack effective methods for promoting bone regeneration and tissue repair, and there is a need for compounds that can activate the Wnt/β-catenin signaling pathway to enhance stem cell differentiation and proliferation.
Innovation Solution
The use of γ-diketones or their salts as Wnt/β-catenin signaling pathway activators, administered to patients to increase stem cell, progenitor cell, or differentiated cell populations, promoting cell proliferation, survival, and tissue regeneration in various tissues including bone, hair, and neural cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments for osteoporosis and bone defects are used, then existing therapeutic options are maintained, but effective bone regeneration and tissue repair are not achieved
Solution Approach 1:
The patent employs γ-diketone compounds with specific molecular structures (Formula I-IV) that act as small molecule activators of the Wnt/β-catenin signaling pathway. These compounds bind to and activate Frizzled receptors, triggering downstream signaling that promotes osteoblast differentiation and bone formation, thereby fundamentally changing the therapeutic mechanism from symptomatic management to active pathway modulation
Solution Approach 2:
The γ-diketone compounds serve as chemical intermediaries that bridge the gap between external treatment and internal biological response. These small molecules act as mediators that transmit the activation signal to the Wnt pathway components, enabling controlled stimulation of bone regeneration without requiring direct cellular manipulation or complex biologic agents
2Productivity
If stem cell differentiation and proliferation are not actively promoted, then current treatment limitations persist, but tissue repair and regeneration are enhanced through Wnt pathway activation
Solution Approach 1:
The γ-diketone compounds modify the activation state of the Wnt/β-catenin pathway by stabilizing β-catenin and preventing its degradation by the destruction complex. This parameter change in pathway activity directly stimulates stem cell proliferation and differentiation into osteoblasts, achieving high productivity through simple small molecule administration rather than complex cellular therapies
Data Source
AI summary
The present disclosure provides γ-diketones or analogs thereof, that activate Wnt/β-catenin signaling and thus treat or prevent diseases related to signal transduction, such as osteoporosis and osteoarthropathy; osteogenesis imperfecta, bone defects, bone fractures, periodontal disease, otosclerosis, wound healing, craniofacial defects, oncolytic bone disease, traumatic brain injuries or spine injuries, brain atrophy/neurological disorders related to the differentiation and development of the central nervous system, including Parkinson's disease, strokes, ischemic cerebral disease, epilepsy, Alzheimer's disease, depression, bipolar disorder, schizophrenia; otic disorders like cochlear hair cell loss; eye diseases such as age related macular degeneration, diabetic macular edema or retinitis pigmentosa and diseases related to differentiation and growth of stem cell, such as hair loss, hematopoiesis related diseases and tissue regeneration related diseases.